Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
-
- Jason G. Kettle
- Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- Husam Alwan
- Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- Michal Bista
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Jason Breed
- Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Nichola L. Davies
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Kay Eckersley
- Discovery Sciences, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- Shaun Fillery
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Kevin M. Foote
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Louise Goodwin
- Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- David R. Jones
- Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- Helena Käck
- Discovery Sciences, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden
-
- Alan Lau
- Oncology Innovative Medicines Unit, AstraZeneca, 35S47 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- J. Willem M. Nissink
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Jon Read
- Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- James S. Scott
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Ben Taylor
- Discovery Sciences, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
- Graeme Walker
- Discovery Sciences, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom
-
- Lisa Wissler
- Discovery Sciences, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden
-
- Marta Wylot
- Oncology Innovative Medicines Unit, AstraZeneca, Unit 310, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
この論文をさがす
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 59 (6), 2346-2361, 2016-02-16
American Chemical Society (ACS)